GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hemostemix Inc (OTCPK:HMTXF) » Definitions » 5-Year Yield-on-Cost %

HMTXF (Hemostemix) 5-Year Yield-on-Cost % : 0.00 (As of Apr. 10, 2025)


View and export this data going back to 2015. Start your Free Trial

What is Hemostemix 5-Year Yield-on-Cost %?

Hemostemix's yield on cost for the quarter that ended in Sep. 2024 was 0.00.


The historical rank and industry rank for Hemostemix's 5-Year Yield-on-Cost % or its related term are showing as below:



HMTXF's 5-Year Yield-on-Cost % is not ranked *
in the Biotechnology industry.
Industry Median: 1.785
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of Hemostemix's 5-Year Yield-on-Cost %

For the Biotechnology subindustry, Hemostemix's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hemostemix's 5-Year Yield-on-Cost % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hemostemix's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Hemostemix's 5-Year Yield-on-Cost % falls into.


;
;

Hemostemix 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Hemostemix is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Hemostemix  (OTCPK:HMTXF) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Hemostemix 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Hemostemix's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Hemostemix Business Description

Traded in Other Exchanges
Address
707 - 7th Avenue SouthWest, Suite 1150, Calgary, AB, CAN, T2P 3H6
Hemostemix Inc is a biotechnology company. The company's principal business activity is developing, manufacturing, and commercializing blood-derived cell therapies for medical conditions. The Company's technology is a platform for developing autologous cell therapies to treat vascular diseases. The Company's clinical stage consists of ACP-01, autologous cell therapy for the treatment of critical limb ischemia.